News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Protector post# 170520

Friday, 09/05/2014 2:14:56 AM

Friday, September 05, 2014 2:14:56 AM

Post# of 347009

The board has been speculating in the past about the possible involvement of Jeanette Bleecker and/or
Angela Thompson.



Another red alert, but first, the lawsuit vs CSM in Fargo, ND will all hopefully come to a closure soon, and I its possible to imagine that the dose switching work at CSM was not contained to only one female, but certainly possible.

Anyhow, what are the odds... that all this time I speak about the links that show Peregrine is collaborating with Ambit Biosciences, and now we have a direct route leading right back to Angela Thompson Geiger-ex CSM employee and worked under Jeanette Bleecker.


RECEPTOS

Faheem Hasnain
President and CEO


Mr. Hasnain has served as our President, Chief Executive Officer and one of our directors since November 2010. Prior to joining us, Mr. Hasnain was the President and Chief Executive Officer and a director of Facet Biotech Corporation, a biology driven antibody company with a focus in multiple sclerosis and oncology. He held that position from December 2008 until the company's acquisition by Abbott Laboratories in April 2010. Previously, Mr. Hasnain was President, Chief Executive Officer and a director of PDL BioPharma, Inc. from October 2008 until Facet Biotech was spun off from PDL BioPharma in December 2008. From October 2004 to September 2008, Mr. Hasnain served at Biogen Idec Inc., a biotechnology company specializing in neurological disorders, autoimmune disorders and cancer, most recently as Executive Vice President in charge of the oncology/rheumatology strategic business unit. Prior to Biogen Idec, Mr. Hasnain held roles with Bristol Myers Squibb, where he was President of the Oncology Therapeutics Network, and for 14 years at GlaxoSmithKline and its predecessor organizations. Mr. Hasnain was appointed Chairman of the Board of Ambit Biosciences Corporation in November 2010 and serves on the board of directors of Aragon Pharmaceuticals. He has been Chairman of the Board of Sente, Inc. since 2008 and served as a member of the board of directors of Tercica, Inc. Mr. Hasnain received a B.H.K. and B.Ed. from the University of Windsor Ontario in Canada.

http://www.receptos.com/board-of-directors-at-receptos.php

http://www.ambitbio.com/Board_of_Directors



and we know there has always been multiple, direct ties to BMS to Ambit

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=103127149&txt2find=ambit

---------------------------------------------------------

..... and how may one ask is Angela Thompson involved? BMS ties ? C'mon, everyone must agree that the odds of this are slim to none and my goal, as always.... is making sure another Fargo does not come close, ever again. So when I see an ex-CSM employee with ties to a collaborator of Peregrine ( based on employee linkedin profiles), then Peregrine should be aware.... so here you go Tustin. Since its only Sept 5, she may still be in orientation....

Clinical Supply Chain Specialist
Receptos, Inc.
September 2014 – Present (1 month)

Project Manager, Global Clinical Supplies
PPD
June 2013 – April 2014 (11 months)Morrisville, NC (RTP)

Operations Project Manager
Clinical Supplies Management
August 2011 – March 2013 (1 year 8 months)

Newly Married and another job as a gift


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y